No Data
NTT, Kansai Electric, etc. (additional) Rating
Upgrade - Bullish Code Stock Name Securities Company Previous After Change ---------------------------------------------- <9502> Chubu Electrical Utilities Daiwa '3' '2' <9504> China Electrical Utilities Daiwa '4' '3' <9505> Hokuriku Electrical Utilities Daiwa '4' '3' <9506> Tohoku Electrical Utilities Daiwa '4' '3' <9508> Kyushu Electrical Utilities Daiwa '3' '2' Target Stock Price Change Code Stock Name Securities Company Previous After Change --------------------------
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
Metastatic Castration-Sensitive Prostate Cancer Clinical Trial Pipeline Insights Featuring 35+ Companies | DelveInsight
Nikkei Stock Average Contribution Ranking (pre-closing) ~ Nikkei Average rises for the fourth day, with Toshiba Electronic pushing up approximately 128 yen per share.
At the closing time 15 days ago, the number of surging stocks in the Nikkei average constituent stocks was 182, with 42 declining and 1 unchanged. The Nikkei average continued to rise for 4 business days. It closed the morning session at 40,232.45 yen, up 626.65 yen (+1.58%) from the previous trading day, with an estimated volume of 804 million 40 million shares. The U.S. stock market on the 14th continued to rise. The Dow Inc rose by 201.36 points to 43,065.22 points, and the nasdaq ended trading at 18,502.69, up 159.75 points.
The Nikkei average started 255 yen higher, with First Retail and Mitsubishi UFJ among the gainers.
[Nikkei Average Stock Price・TOPIX (table)] Nikkei Average; 39636.87; +255.98 TOPIX; 2720.57; +7.90 [Morning Situation] On the 11th, the Nikkei Average started trading up 255.98 yen at 39636.87 yen for the third consecutive day. The US stock market on the previous day, the 10th, fell. Dow Jones Industrial Average closed at 42454.12 dollars, down 57.88 dollars, and NASDAQ closed at 18282.05, down 9.57 points. The Consumer Price Index (CPI) exceeded financial estimates.
Pfizer Reports Positive Phase 3 Results for Talzenna/Xtandi Combo
No Data
No Data
